JP2018506534A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018506534A5 JP2018506534A5 JP2017541934A JP2017541934A JP2018506534A5 JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5 JP 2017541934 A JP2017541934 A JP 2017541934A JP 2017541934 A JP2017541934 A JP 2017541934A JP 2018506534 A5 JP2018506534 A5 JP 2018506534A5
- Authority
- JP
- Japan
- Prior art keywords
- ghr
- stat5
- socs
- halogen
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229910052739 hydrogen Inorganic materials 0.000 claims 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 claims 10
- 102100032218 Cytokine-inducible SH2-containing protein Human genes 0.000 claims 8
- 102100020948 Growth hormone receptor Human genes 0.000 claims 8
- 102000001712 STAT5 Transcription Factor Human genes 0.000 claims 8
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 229910052736 halogen Inorganic materials 0.000 claims 8
- 150000002367 halogens Chemical class 0.000 claims 8
- 150000002431 hydrogen Chemical class 0.000 claims 8
- 239000001257 hydrogen Substances 0.000 claims 8
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims 6
- 239000008194 pharmaceutical composition Substances 0.000 claims 6
- 108090000623 proteins and genes Proteins 0.000 claims 6
- 101000943420 Homo sapiens Cytokine-inducible SH2-containing protein Proteins 0.000 claims 5
- 101001075374 Homo sapiens Gamma-glutamyl hydrolase Proteins 0.000 claims 5
- 101100534458 Homo sapiens STAT5A gene Proteins 0.000 claims 5
- 101000664737 Homo sapiens Somatotropin Proteins 0.000 claims 5
- 102000004877 Insulin Human genes 0.000 claims 5
- 229940125396 insulin Drugs 0.000 claims 5
- 108010033419 somatotropin-binding protein Proteins 0.000 claims 5
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 4
- 102000004169 proteins and genes Human genes 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 101710132484 Cytokine-inducible SH2-containing protein Proteins 0.000 claims 3
- 101001075287 Homo sapiens Growth hormone receptor Proteins 0.000 claims 3
- 101000976075 Homo sapiens Insulin Proteins 0.000 claims 3
- 101000599951 Homo sapiens Insulin-like growth factor I Proteins 0.000 claims 3
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims 3
- 108010029477 STAT5 Transcription Factor Proteins 0.000 claims 3
- 239000003937 drug carrier Substances 0.000 claims 3
- 230000002401 inhibitory effect Effects 0.000 claims 3
- 230000001105 regulatory effect Effects 0.000 claims 3
- 108090001061 Insulin Proteins 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
- 0 **1C=CC(OCc([o]2)nnc2SCCCN(C(C=C*(*)C=C2)=C2N2)C2=O)=CC=C1 Chemical compound **1C=CC(OCc([o]2)nnc2SCCCN(C(C=C*(*)C=C2)=C2N2)C2=O)=CC=C1 0.000 description 2
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562115356P | 2015-02-12 | 2015-02-12 | |
| US62/115,356 | 2015-02-12 | ||
| PCT/US2016/017717 WO2016130901A2 (en) | 2015-02-12 | 2016-02-12 | Blockers of the growth hormone receptor in disease prevention and treatment |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021018032A Division JP2021075553A (ja) | 2015-02-12 | 2021-02-08 | 疾患予防および治療における成長ホルモン受容体の遮断剤 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018506534A JP2018506534A (ja) | 2018-03-08 |
| JP2018506534A5 true JP2018506534A5 (enExample) | 2019-03-28 |
| JP6930916B2 JP6930916B2 (ja) | 2021-09-01 |
Family
ID=56615057
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017541934A Active JP6930916B2 (ja) | 2015-02-12 | 2016-02-12 | 疾患予防および治療における成長ホルモン受容体の遮断剤 |
| JP2021018032A Pending JP2021075553A (ja) | 2015-02-12 | 2021-02-08 | 疾患予防および治療における成長ホルモン受容体の遮断剤 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021018032A Pending JP2021075553A (ja) | 2015-02-12 | 2021-02-08 | 疾患予防および治療における成長ホルモン受容体の遮断剤 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10246446B2 (enExample) |
| EP (1) | EP3256465B1 (enExample) |
| JP (2) | JP6930916B2 (enExample) |
| KR (1) | KR20180016333A (enExample) |
| CN (1) | CN107438605B (enExample) |
| AU (1) | AU2016219173B2 (enExample) |
| BR (1) | BR112017017182A2 (enExample) |
| CA (1) | CA2976219C (enExample) |
| ES (1) | ES2871551T3 (enExample) |
| IL (1) | IL253943A0 (enExample) |
| MX (1) | MX383010B (enExample) |
| NZ (1) | NZ734252A (enExample) |
| RU (1) | RU2726254C2 (enExample) |
| WO (1) | WO2016130901A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| CN112153974A (zh) | 2018-03-15 | 2020-12-29 | 南加利福尼亚大学 | 禁食模仿膳食(fmd)而非仅饮水禁食促进炎症和ibd病理学的逆转 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE9701010D0 (sv) * | 1997-03-19 | 1997-03-19 | Pharmacia & Upjohn Ab | Antibody |
| JPWO2002096892A1 (ja) | 2001-05-31 | 2004-09-09 | 小野薬品工業株式会社 | オキサジアゾール誘導体化合物およびその化合物を有効成分とする薬剤 |
| WO2006001770A1 (en) * | 2004-06-28 | 2006-01-05 | Biovitrum Ab | Method for identifying modulators of cytokine class i receptor |
| RU2415134C9 (ru) * | 2005-08-15 | 2011-05-27 | Этерна Центарис ГмбХ | Способ лечения или профилактики физиологических и/или патофизиологических состояний, опосредуемых рецепторами, стимулирующими секрецию гормона роста, триазолы и фармацевтическая композиция на их основе |
| US8519137B2 (en) | 2007-10-11 | 2013-08-27 | Vertex Pharmaceuticals Incorporated | Heteroaryl amides useful as inhibitors of voltage-gated sodium channels |
| AU2008352540B2 (en) * | 2008-03-14 | 2012-06-28 | Biocon Limited | A monoclonal antibody and a method thereof |
| JP5731501B2 (ja) * | 2009-07-28 | 2015-06-10 | コーニンクレッカ フィリップス エヌ ヴェ | ロック構造を有するハウジング |
| RU2014123030A (ru) * | 2011-12-22 | 2016-02-20 | Ринат Ньюросайенс Корп. | Антагонистические антитела против человеческого рецептора гормона роста и способы их применения |
| WO2013123511A1 (en) * | 2012-02-16 | 2013-08-22 | New York University | Control of hypoxia-inducible gene expression with oligooxopiperazine nonpeptidic helix mimetics |
| WO2013192165A2 (en) | 2012-06-20 | 2013-12-27 | University Of Kansas | Compounds and methods for activating the apoptotic arm of the unfolded protein response |
| KR20150124962A (ko) | 2013-02-12 | 2015-11-06 | 유니버시티 오브 써던 캘리포니아 | 화학 독성 및 연령 관련 질병으로부터 보호하기 위한 방법 및 규정식 |
-
2016
- 2016-02-12 BR BR112017017182A patent/BR112017017182A2/pt not_active IP Right Cessation
- 2016-02-12 US US14/913,130 patent/US10246446B2/en active Active
- 2016-02-12 AU AU2016219173A patent/AU2016219173B2/en not_active Ceased
- 2016-02-12 ES ES16749947T patent/ES2871551T3/es active Active
- 2016-02-12 JP JP2017541934A patent/JP6930916B2/ja active Active
- 2016-02-12 KR KR1020177024899A patent/KR20180016333A/ko not_active Ceased
- 2016-02-12 WO PCT/US2016/017717 patent/WO2016130901A2/en not_active Ceased
- 2016-02-12 MX MX2017010306A patent/MX383010B/es unknown
- 2016-02-12 NZ NZ734252A patent/NZ734252A/en not_active IP Right Cessation
- 2016-02-12 CN CN201680010133.4A patent/CN107438605B/zh active Active
- 2016-02-12 EP EP16749947.4A patent/EP3256465B1/en active Active
- 2016-02-12 RU RU2017129335A patent/RU2726254C2/ru active
- 2016-02-12 CA CA2976219A patent/CA2976219C/en active Active
-
2017
- 2017-08-10 IL IL253943A patent/IL253943A0/en unknown
-
2019
- 2019-03-27 US US16/366,662 patent/US20190276445A1/en not_active Abandoned
-
2021
- 2021-02-08 JP JP2021018032A patent/JP2021075553A/ja active Pending